-
MyChart
Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
- Donate Today
August marks the end of OncoLog’s 62 years of publication. The current issue will be the final one.
MD Anderson Cancer Center has published OncoLog continuously since 1956, when it was called simply Newsletter. The name was changed to OncoLog in 1983. OncoLog became available online in 2003.
Although the name and look of the newsletter have changed over the years, its mission has...
Almost one year after the Food and Drug Administration (FDA) approval of chimeric antigen receptor (CAR) T-cell therapy for children with...
MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey...
A well-trained research workforce is essential for addressing both
current and future health challenges in the U.S. However, according to
a 2012 report from the National Institutes of Health (NIH) Biomedical
Research Workforce Working Group, the proportion of biomedical and
behavioral research trainees that progress to established academic
research positions is declining.
In 1993, 34 percent of all Ph.D. students went on to...
MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, have launched Magnolia...
Many are aware of the importance of cancer research for the discovery of new therapies and treatment options, but perhaps less well-known...
A study led by MD Anderson found the investigational drug quizartinib prolongs overall survival for patients with a deadly form of acute myeloid...
When Elizabeth White started a new job as executive director of the Michigan Ovarian Cancer Alliance in 2017, she decided it...
A drug discovered and advanced by MD Anderson’s Institute for Applied Cancer Science (IACS) and the Center for Co-Clinical Trials (CCCT) inhibits...